Advances in drug delivery technology are enabling the development of effective oral GLP-1 therapies, such as oral semaglutide, expanding the potential patient base
second, the importance of IGF-1 monitoring as the central safety parameter in study models
Some reports have suggested a potential increase in suicidality risk associated with semaglutide, though the preponderance of current evidence does not indicate a heightened risk ( 13 , 14 )
For example, obesity and visceral fat accumulation showed positive association with DPN, and insulin resistance can be involved in this pathophysiology observed in T2DM [11]
Its also abundant in animal products, including red meat, poultry, and seafood